首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Pharmacological evaluation of Alstonia scholaris: anti-tussive, anti-asthmatic and expectorant activities.
【24h】

Pharmacological evaluation of Alstonia scholaris: anti-tussive, anti-asthmatic and expectorant activities.

机译:Alstonia Scholaris的药理评价:镇咳,平喘和祛痰活性。

获取原文
获取原文并翻译 | 示例
           

摘要

ETHNOPHARMACOLOGICAL RELEVANCE: Alstonia scholaris (Apocynaceae) was documented as an effective herb for the treatment of chronic respiratory diseases in "dai" ethnopharmacy historically, and its leaf crude extract, used for releasing tracheitis and cold symptom, was approved to be a commercial formulation by State Food and Drugs Administration of China (SFDA). AIM OF THE STUDY: The investigation evaluates the anti-tussive and anti-asthmatic activities of the ethanolic extract, fractions and main alkaloids of Alstonia scholaris leaf to provide experimental evidence for its traditional and modern clinical use. For our most interesting, is to reveal the active components for further new drug development. MATERIALS AND METHODS: The leaf of Alstonia scholaris was extracted with ethanol and then separated into different fractions. Furthermore, alkaloids were isolated by phytochemical method. The anti-tussive activity was evaluated using three different models including ammonia or sulfur dioxide induced mice coughing, and citric acid induced guinea pigs coughing. The anti-asthmatic activity was investigated on guinea pigs bronchoconstraction induced by histamine. The expectorant activity was evaluated by volume of phenol red in mice's tracheas. RESULTS: The alkaloids fraction significantly inhibited mice's frequency of cough induced by ammonia, increased mice's latent period of cough induced by sulfur dioxide, and increased guinea pigs' latent period of cough and inhibited frequency of cough. Besides, the alkaloids fraction increased delitescence of convulsion, and tumble of guinea pigs in anti-asthmatic test, and enhanced tracheal phenol red output in expectorant evaluation. Moreover, the main alkaloid, picrinine exhibited anti-tussive and anti-asthmatic activities in vivo. CONCLUSIONS: The alkaloids fraction was anti-tussive, anti-asthmatic and expectorant activities component of Alstonia scholaris leaf, and it may also be a valuable lead material for respiratory diseases drug development. Picrinine, the main anti-tussive and anti-asthmatic compound, could be applied in quality control of products from Alstonia scholaris leaf.
机译:族裔药理关系:历史上,在“ dai族”族裔药房中,Alstonia Scholaris(Apocynaceae)被证明是治疗慢性呼吸道疾病的有效草药,其叶粗提物用于释放气管炎和感冒症状,已被批准为商业制剂国家食品药品监督管理局(SFDA)。研究目的:该研究评估了阿尔斯通叶片的乙醇提取物,级分和主要生物碱的镇咳和平喘活性,为其传统和现代临床应用提供了实验依据。对于我们最有趣的是,揭示进一步开发新药物的活性成分。材料与方法:用乙醇提取阿斯通叶的叶子,然后分成不同的级分。此外,通过植物化学方法分离生物碱。使用三种不同的模型评估镇咳活性,包括氨气或二氧化硫诱导的小鼠咳嗽和柠檬酸诱导的豚鼠咳嗽。研究了由组胺引起的豚鼠支气管收缩的抗哮喘活性。通过小鼠气管中酚红的体积评估祛痰活性。结果:生物碱组分显着抑制氨诱导的小鼠咳嗽频率,增加二氧化硫诱导的小鼠咳嗽潜伏期,并增加豚鼠的咳嗽潜伏期并抑制咳嗽频率。此外,生物碱成分在抗哮喘试验中增加了惊厥的清醒和豚鼠的翻滚,在祛痰评估中增加了气管酚红的输出。此外,主要生物碱苦连碱在体内表现出止咳和抗哮喘活性。结论:生物碱成分是Alstonia Scholaris叶片的镇咳,平喘和祛痰活性成分,也可能是呼吸道疾病药物开发的重要先导材料。苦味素是一种主要的镇咳和止喘药,可用于质量控制阿尔斯通叶片的产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号